⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL487133 | 0.72 | — | — | |
| SCHEMBL870380 | 0.72 | — | — | |
| SCHEMBL12532333 | 0.72 | — | — | |
| SCHEMBL921570 | 0.72 | — | — | |
| SCHEMBL248937 | 0.72 | — | — | |
| SCHEMBL8190946 | 0.67 | — | — | |
| SCHEMBL6513455 | 0.62 | — | — | |
| SCHEMBL1450365 | 0.62 | — | — | |
| SCHEMBL15145389 | 0.62 | — | — | |
| SCHEMBL16272983 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 757 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024112937-A2 | COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER AND METABOLIC DISEASE | PRETZEL THERAPEUTICS, INC. (US) | 2024-05-30 | — | — | WO | claimed |
| US-11965209-B2 | Method for obtaining structural information concerning an encoded molecule and method for selecting compounds | NUEVOLUTION A/S (DK) | 2024-04-23 | — | — | US | claimed |
| WO-2023141302-A1 | MUSK-TARGETING OLIGONUCLEOTIDES | BOLDEN THERAPEUTICS, INC. (US) | 2023-07-27 | — | — | WO | claimed |
| EP-4134414-A1 | LUBRICATING OIL COMPOSITIONS CONTAINING ZIRCONIUM AND METHOD FOR PREVENTING OR REDUCING LOW SPEED PRE-IGNITION IN DIRECT INJECTED SPARK-IGNITED ENGINES | Chevron U.S.A. Inc. (US) | 2023-02-15 | — | — | EP | claimed |
| US-20220205027-A1 | METHOD FOR OBTAINING STRUCTURAL INFORMATION CONCERNING AN ENCODED MOLECULE AND METHOD FOR SELECTING COMPOUNDS | NUEVOLUTION A/S (DK) | 2022-06-30 | — | — | US | claimed |
| EP-3652283-B1 | LUBRICATING OIL COMPOSITIONS CONTAINING ZIRCONIUM AND METHOD FOR PREVENTING OR REDUCING LOW SPEED PRE-IGNITION IN DIRECT INJECTED SPARK-IGNITED ENGINES | CHEVRON ORONITE CO (US) | 2022-06-29 | — | — | EP | claimed |
| US-20220127609-A1 | ANTISENSE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING | PROQR THERAPEUTICS II B.V. (NL) | 2022-04-28 | — | — | US | claimed |
| EP-3924493-A1 | ANTISENSE OLIGONUCLEOTIDES FOR NUCLEIC ACID EDITING | ProQR Therapeutics II B.V. (NL) | 2021-12-22 | — | — | EP | claimed |
| US-11118215-B2 | Method for obtaining structural information concerning an encoded molecule and method for selecting compounds | NUEVOLUTION A/S (DK) | 2021-09-14 | — | — | US | claimed |
| EP-3018206-B1 | ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES | NUEVOLUTION AS (DK) | 2021-08-11 | — | — | EP | claimed |
| EP-0827501-A4 | NON-NUCLEOSIDIC COUMARIN DERIVATIVES AS POLYNUCLEOTIDE-CROSS-LINKING AGENTS | NAXCOR (US) | 1998-06-10 | — | — | EP | claimed |
| EP-0827501-A1 | NON-NUCLEOSIDIC COUMARIN DERIVATIVES AS POLYNUCLEOTIDE-CROSS-LINKING AGENTS | NAXCOR (US) | 1998-03-11 | — | — | EP | claimed |
| WO-1997046569-A2 | 2'-SUBSTITUTED NUCLEOSIDES AND OLIGONUCLEOTIDE DERIVATIVES | NOVARTIS AG (CH) | 1997-12-11 | — | — | WO | claimed |
| JP-H08511002-A | — | — | 1996-11-19 | — | — | JP | claimed |
| WO-1996028438-A1 | NON-NUCLEOSIDIC COUMARIN DERIVATIVES AS POLYNUCLEOTIDE-CROSS-LINKING AGENTS | NAXCOR (US) | 1996-09-19 | — | — | WO | claimed |
| EP-0693065-A4 | NON-NUCLEOSIDIC COUMARIN DERIVATIVES AS POLYNUCLEOTIDE-CROSSLINKING AGENTS | NAXCOR (US) | 1996-03-20 | — | — | EP | claimed |
| EP-0693065-A1 | NON-NUCLEOSIDIC COUMARIN DERIVATIVES AS POLYNUCLEOTIDE-CROSSLINKING AGENTS | NAXCOR (US) | 1996-01-24 | — | — | EP | claimed |
| WO-1994024120-A1 | NON-NUCLEOSIDIC COUMARIN DERIVATIVES AS POLYNUCLEOTIDE-CROSSLINKING AGENTS | NAXCOR (US) | 1994-10-27 | — | — | WO | claimed |
| US-4528140-A | Synthesis of alpha-dithiophosphato amides | THE PROCTER & GAMBLE COMPANY (US) | 1985-07-09 | — | — | US | claimed |
| EP-0131432-A2 | Synthesis of alpha-dithiophosphato amides | THE PROCTER & GAMBLE COMPANY (US) | 1985-01-16 | — | — | EP | claimed |